
Acumen Pharmaceuticals (ABOS) Debt Metrics
Market Cap: $65.42M
Avg Volume: 236.55K
Industry: Biotechnology
Sector: Healthcare
How much debt does Acumen Pharmaceuticals have?
According to Acumen Pharmaceuticals's latest annual financial reports, the company's debt profile is as follows:
Total Debt and Liabilities
Acumen Pharmaceuticals's total debt stands at $28.73M. This is broken down into:
- Long-term debt: $28.60M
- Short-term debt: $133.00K
The company's net debt, which accounts for cash and cash equivalents, is $-6.89M. In terms of overall financial obligations, Acumen Pharmaceuticals's total liabilities amount to $57.18M.
Debt Ratios and Metrics
To better understand Acumen Pharmaceuticals's debt position, we can look at several key ratios:
- Debt to Equity Ratio: 0.16 - this indicates the proportion of equity and debt the company uses to finance its assets.
- Debt Ratio: 12.02% - this shows the proportion of a company's assets that are financed through debt.
- Interest Coverage Ratio: -28.03 - this measures how easily a company can pay interest on its outstanding debt.
- Long-term Debt to Capitalization: 13.53% - this shows the proportion of long-term debt in the company's capital structure.
- Total Debt to Capitalization: 13.65% - this indicates the total debt in the company's capital structure.
These metrics provide insight into Acumen Pharmaceuticals's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.
Total Debt
$28.73M
Long-term Debt
$28.60M
Short-term Debt
$133.00K
Net Debt
$-6.89M
Total Liabilities
$57.18M
Interest Coverage
-28.03
Debt to Equity Ratio
0.16
Debt Ratio
12.02%
Acumen Pharmaceuticals Historical Debt Metrics
Acumen Pharmaceuticals Historical Debt
The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2024.
Year | Total Debt | Long-term Debt | Short-term Debt | Net Debt | Total Liabilities | Debt to Equity | Debt Ratio | Interest Coverage | Long-term Debt to Capitalization | Total Debt to Capitalization |
---|---|---|---|---|---|---|---|---|---|---|
2024 | $28.73M | $28.60M | $133.00K | $-6.89M | $57.18M | 0.16 | 12.02% | -28.03 | 13.53% | 13.65% |
2023 | $28.49M | $27.62M | $1.73M | $-38.40M | $43.15M | 0.11 | 9.19% | 0.00 | 9.29% | 9.64% |
2022 | $105.00K | $- | $210.00K | $-130.00M | $7.81M | 0.00 | 0.05% | 0.00% | 0.06% | |
2021 | $- | $- | $- | $-122.16M | $5.15M | 0.00 | 0.00% | 0.00 | 0.00% | 0.00% |
2020 | $- | $- | $- | $-43.78M | $63.02M | 0.00 | 0.00% | 0.00 | 0.00% | 0.00% |
2019 | $- | $- | $- | $-6.55M | $18.74M | 0.00 | 0.00% | 0.00 | 0.00% | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for ABOS.